8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of chitin-architected spatiotemporal three-dimensional culture microenvironments on human umbilical cord-derived mesenchymal stem cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mesenchymal stem cell (MSC) transplantation has been explored for the clinical treatment of various diseases. However, the current two-dimensional (2D) culture method lacks a natural spatial microenvironment in vitro. This limitation restricts the stable establishment and adaptive maintenance of MSC stemness. Using natural polymers with biocompatibility for constructing stereoscopic MSC microenvironments may have significant application potential. This study used chitin-based nanoscaffolds to establish a novel MSC three-dimensional (3D) culture. We compared 2D and 3D cultured human umbilical cord-derived MSCs (UCMSCs), including differentiation assays, cell markers, proliferation, and angiogenesis. When UCMSCs are in 3D culture, they can differentiate into bone, cartilage, and fat. In 3D culture condition, cell proliferation is enhanced, accompanied by an elevation in the secretion of paracrine factors, including vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), Interleukin-6 (IL-6), and Interleukin-8 (IL-8) by UCMSCs. Additionally, a 3D culture environment promotes angiogenesis and duct formation with HUVECs (Human Umbilical Vein Endothelial Cells), showing greater luminal area, total length, and branching points of tubule formation than a 2D culture. MSCs cultured in a 3D environment exhibit enhanced undifferentiated, as well as higher cell activity, making them a promising candidate for regenerative medicine and therapeutic applications.

          Graphical abstract

          This study utilized chitin-based nanoscaffolds to establish a three-dimensional (3D) culture of Human Umbilical Cord Mesenchymal Stem Cells (UCMSCs), comparing their characteristics with traditional two-dimensional (2D) cultures. The findings indicate that the 3D culture preserved the stemness and differentiation capabilities of the UCMSCs while enhancing their proliferative abilities. Additionally, an upregulation in the secretion of paracrine factors, including Vascular Endothelial Growth Factor (VEGF), Hepatocyte Growth Factor (HGF), Interleukin-6 (IL-6), and Interleukin-8 (IL-8), was observed. The supernatant from UCMSCs in 3D culture significantly enhanced the lumen area, total length, and branching points of the tubular structures formed by Human Umbilical Vein Endothelial Cells (HUVECs). These findings suggest that chitosan-based nano-scaffolds show promise as biomaterials for the early in-vitro culture of artificial MSCs, positioning them as ideal candidates for regenerative medicine and therapeutic applications.

          Highlights

          • 3D culture with chitin materials preserves stemness, differentiation potential, proliferative capacity, and paracrine effects of human umbilical cord-derived mesenchymal stem cells (UCMSCs) better than 2D culture.

          • mRNA analysis of UCMSCs in 3D culture shows significant upregulation of expression, including genes such as CXCL12, MCM8, and MCM10.

          • 3D culture with chitin material provides an in vivo-like microenvironment for culturing mesenchymal stem cells (MSCs).

          • High-quality methods and strategies are very useful for producing high-quality MSCs and expanding their clinical application.

          Related collections

          Most cited references54

          • Record: found
          • Abstract: found
          • Article: not found

          Mesenchymal stem cells in health and disease.

          Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells that can be isolated from many adult tissues. They can differentiate into cells of the mesodermal lineage, such as adipocytes, osteocytes and chondrocytes, as well as cells of other embryonic lineages. MSCs can interact with cells of both the innate and adaptive immune systems, leading to the modulation of several effector functions. After in vivo administration, MSCs induce peripheral tolerance and migrate to injured tissues, where they can inhibit the release of pro-inflammatory cytokines and promote the survival of damaged cells. This Review discusses the targets and mechanisms of MSC-mediated immunomodulation and the possible translation of MSCs to new therapeutic approaches.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Stem cells and niches: mechanisms that promote stem cell maintenance throughout life.

            Niches are local tissue microenvironments that maintain and regulate stem cells. Long-predicted from mammalian studies, these structures have recently been characterized within several invertebrate tissues using methods that reliably identify individual stem cells and their functional requirements. Although similar single-cell resolution has usually not been achieved in mammalian tissues, principles likely to govern the behavior of niches in diverse organisms are emerging. Considerable progress has been made in elucidating how the microenvironment promotes stem cell maintenance. Mechanisms of stem cell maintenance are key to the regulation of homeostasis and likely contribute to aging and tumorigenesis when altered during adulthood.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Clinical Trials With Mesenchymal Stem Cells: An Update.

              In the last year, the promising features of mesenchymal stem cells (MSCs), including their regenerative properties and ability to differentiate into diverse cell lineages, have generated great interest among researchers whose work has offered intriguing perspectives on cell-based therapies for various diseases. Currently the most commonly used adult stem cells in regenerative medicine, MSCs, can be isolated from several tissues, exhibit a strong capacity for replication in vitro, and can differentiate into osteoblasts, chondrocytes, and adipocytes. However, heterogeneous procedures for isolating and cultivating MSCs among laboratories have prompted the International Society for Cellular Therapy (ISCT) to issue criteria for identifying unique populations of these cells. Consequently, the isolation of MSCs according to ISCT criteria has produced heterogeneous, nonclonal cultures of stromal cells containing stem cells with different multipotent properties, committed progenitors, and differentiated cells. Though the nature and functions of MSCs remain unclear, nonclonal stromal cultures obtained from bone marrow and other tissues currently serve as sources of putative MSCs for therapeutic purposes, and several findings underscore their effectiveness in treating different diseases. To date, 493 MSC-based clinical trials, either complete or ongoing, appear in the database of the US National Institutes of Health. In the present article, we provide a comprehensive review of MSC-based clinical trials conducted worldwide that scrutinizes biological properties of MSCs, elucidates recent clinical findings and clinical trial phases of investigation, highlights therapeutic effects of MSCs, and identifies principal criticisms of the use of these cells. In particular, we analyze clinical trials using MSCs for representative diseases, including hematological disease, graft-versus-host disease, organ transplantation, diabetes, inflammatory diseases, and diseases in the liver, kidney, and lung, as well as cardiovascular, bone and cartilage, neurological, and autoimmune diseases.
                Bookmark

                Author and article information

                Contributors
                Journal
                Bioact Mater
                Bioact Mater
                Bioactive Materials
                KeAi Publishing
                2452-199X
                09 February 2024
                May 2024
                09 February 2024
                : 35
                : 291-305
                Affiliations
                [a ]Department of Cardiac Surgery, University of Tokyo, Tokyo, 113-8655, Japan
                [b ]Department of Cell Therapy in Regenerative Medicine, University of Tokyo Hospital, Tokyo, 113-8655, Japan
                [c ]Nissan Chemical Corporation, Tokyo, 103-0027, Japan
                [d ]Winhealth Pharma, 999077, Hong Kong
                Author notes
                []Corresponding author. jou.sur@ 123456mail.u-tokyo.ac.jp
                [∗∗ ]Corresponding author. ONO-THO@ 123456h.u-tokyo.ac.jp
                Article
                S2452-199X(24)00024-0
                10.1016/j.bioactmat.2024.01.014
                10869358
                a2a7da22-57e0-4bef-9788-6eab48e683a1
                © 2024 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 16 November 2023
                : 11 January 2024
                : 15 January 2024
                Categories
                Article

                cellhesion® chitin nanoscaffolds,mesenchymal stem cells,stemness,3d culture

                Comments

                Comment on this article